A minimally invasive approach in the treatment of vesicoureteral reflux in neurogenic bladder in children.
Mosiello
Giovanni
G
Salsano
Maria L
ML
Pascali
Maria P
MP
Camanni
Daniela
D
De Gennaro
Mario
M
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002648:Child; D003131:Combined Modality Therapy; D003911:Dextrans; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid; D008297:Male; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D001750:Urinary Bladder, Neurogenic / Q000150:complications*; D014718:Vesico-Ureteral Reflux / Q000188:drug therapy* / Q000209:etiology
D003911:Dextrans; D009465:Neuromuscular Agents; C487487:dextranomer-hyaluronic acid copolymer; D006820:Hyaluronic Acid; D019274:Botulinum Toxins, Type A